BRISTOL MYERS SQUIBB PHARMA COMPANY has a total of 31 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1996. It filed its patents most often in Australia, Ukraine and Hong Kong. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are TAIGEN BIOTECHNOLOGY CO LTD, SHENZHEN CHIPSCREEN BIOSCIENCES LTD and KEZAR LIFE SCIENCES.
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Medical technology | |
#5 | Environmental technology | |
#6 | Packaging and shipping |
# | Name | Total Patents |
---|---|---|
#1 | Mertzman Michael E | 2 |
#2 | Carpenter Alan P Jr | 2 |
#3 | Mimi L Quan | 2 |
#4 | Wrobleski Stephen T | 2 |
#5 | Zhang Yanlei | 2 |
#6 | Rajopadhye Milind | 2 |
#7 | Lee Taekyu | 2 |
#8 | James R Pruitt | 2 |
#9 | Moslin Ryan M | 2 |
#10 | Chen Wenting | 2 |
Publication | Filing date | Title |
---|---|---|
AU2003203805A1 | Succinoylamino lactams as inhibitors of ABeta protein production | |
AU2055301A | Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease | |
AU1761601A | Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain | |
UA72207C2 | Pharmaceutical formulations of efavirenz and disintegrants providing for increasing dissolution rate and process of manufacturing such tablets or capsules |